$IMLFF The company continues to focus on research into fundamental benefits of cannabinoid drugs to address high unmet medical needs, selective advancement of high-potential drug candidates, identification and retention of industry veterans to define and execute the present & future drug development programs in a time- and cost-effective manner, collaboration with biotech-savvy investor groups & exploration into the partnership potential of the various programs and assets.

Get InMed Pharmaceuticals full pipeline and company prospects in the FULL REPORT

(Copy and paste to your browser may be required to view the full report- http://bit.ly/2kA730w-IMLFF-Analyst)

https://finance.yahoo.com/news/inmeds-cannabi...00009.html